Form 4: Organogenesis Holdings Inc. Executive Exercises Stock Options

Patrick Bilbo, Chief Operating Officer of Organogenesis Holdings Inc., exercised stock options to acquire 152,250 shares of Class A Common Stock at $1.18 per share on March 28, 2024.

Summary

• On March 28, 2024, Patrick Bilbo, the Chief Operating Officer of Organogenesis Holdings Inc., exercised stock options.
• This transaction involved the acquisition of 152,250 shares of Class A Common Stock at a price of $1.18 per share.
• Following the transaction, Bilbo directly owns 811,579 shares of Class A Common Stock.
• The stock options were fully vested and exercisable on the transaction date, with an expiration date of April 10, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. The exercise of options could be seen as positive, but without further context, it's difficult to assess the overall impact.

Positives

• The exercise of stock options by a key executive could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings in the company's stock.

Stakeholder Impact

• The transaction could have a minor impact on shareholders due to the increase in the number of outstanding shares.

Key Dates